Edition:
United States

Gemphire Therapeutics Inc (GEMP.OQ)

GEMP.OQ on NASDAQ Stock Exchange Global Market

1.57USD
4:00pm EDT
Change (% chg)

$-0.08 (-4.85%)
Prev Close
$1.65
Open
$1.66
Day's High
$1.68
Day's Low
$1.55
Volume
99,723
Avg. Vol
110,810
52-wk High
$11.41
52-wk Low
$0.83

Get access to over 18 million research reports from over 1,700 sources.

For several years, Reuters.com has provided analyst research reports for downloading. In an effort to streamline our website, analyst research will now be available from our dedicated page for Thomson Reuters On Demand, and the Reuters service will discontinue as of September 30, 2016.

Thomson Reuters On Demand provides over 18 million research reports from 1,700 sources.

Moreover, Thomson Reuters On Demand offers fast and cost-effective solutions that would allow you to retrieve information on:

  • ownership
  • filings
  • deals
  • private equity
  • third-party document and information retrieval
  • estimates
  • fundamentals
  • economics
  • events
  • news
  • and much, much more…

Click here to request a report and the team of expert analysts will get back to you shortly, to ensure you get the report you need.

Name Age Since Current Position

Charles Bisgaier

63 2014 Chairman of the Board, Chief Scientific Officer

Steven Gullans

65 2018 President, Chief Executive Officer, Director

Jeffrey Mathiesen

56 2015 Chief Financial Officer

Lee Golden

49 2016 Chief Medical Officer

Seth Reno

50 Chief Commercial Officer